• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于标记物关联数据的疾病风险评估。在血色素沉着症高危个体中的应用。

Disease risk estimates from marker association data. Application to individuals at risk for hemochromatosis.

作者信息

Lin H J, Conte W J, Rotter J I

出版信息

Clin Genet. 1985 Feb;27(2):127-33. doi: 10.1111/j.1399-0004.1985.tb00199.x.

DOI:10.1111/j.1399-0004.1985.tb00199.x
PMID:3856493
Abstract

The recessive hemochromatosis gene is both linked to the HLA region on chromosome 6 and nonrandomly associated with certain HLA alleles. The use of linked HLA markers to trace known hemochromatosis genes within a family is well known, but using the population associations to detect unsuspected disease genes has not been fully appreciated. Thus, while HLA typing has been utilized to detect asymptomatic affected siblings, it has not been applied to other relatives. We propose a method in which Bayes' rule is used to calculate the probability that designated HLA marker haplotypes, brought into the family by spouses, have attendant hemochromatosis genes. The A3, B14 and A3, B7 haplotypes are such high risk markers. When these haplotypes are inherited from the unaffected parent, the offspring of an individual with hemochromatosis is at marked increased risk for the disease. When A3 and B14 are absent from the HLA marker haplotype, however, the risk of having a hemochromatosis gene is less than that for the general population. This approach should be helpful in identifying family members at a higher risk for developing the disease and who may then undergo appropriate periodic screening.

摘要

隐性血色素沉着症基因既与6号染色体上的HLA区域连锁,又与某些HLA等位基因非随机关联。利用连锁的HLA标记来追踪家族中已知的血色素沉着症基因是众所周知的,但利用群体关联性来检测未被怀疑的疾病基因尚未得到充分认识。因此,虽然HLA分型已被用于检测无症状的患病同胞,但尚未应用于其他亲属。我们提出一种方法,其中使用贝叶斯法则来计算配偶带入家族的指定HLA标记单倍型携带血色素沉着症基因的概率。A3、B14和A3、B7单倍型就是这样的高风险标记。当这些单倍型从未患病的父母遗传而来时,血色素沉着症患者的后代患该病的风险显著增加。然而,当HLA标记单倍型中不存在A3和B14时,携带血色素沉着症基因的风险低于一般人群。这种方法有助于识别患该病风险较高的家庭成员,然后这些成员可接受适当的定期筛查。

相似文献

1
Disease risk estimates from marker association data. Application to individuals at risk for hemochromatosis.基于标记物关联数据的疾病风险评估。在血色素沉着症高危个体中的应用。
Clin Genet. 1985 Feb;27(2):127-33. doi: 10.1111/j.1399-0004.1985.tb00199.x.
2
The use of association data to identify family members at high risk for marker-linked diseases.利用关联数据识别与标记物相关疾病高危家庭成员。
Am J Hum Genet. 1984 Jan;36(1):152-66.
3
A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association.一项针对609个标记血色素沉着症基因的HLA单倍型的研究:(1)该基因在HLA - A位点附近的定位以及定义杂合子群体所需的特征,(2)关于血色素沉着症与HLA关联潜在原因的假说。
Am J Hum Genet. 1987 Aug;41(2):89-105.
4
[Idiopathic hemochromatosis. Immunogenetics and diagnosis. Prevention by HLA genotypes].[特发性血色素沉着症。免疫遗传学与诊断。通过HLA基因型进行预防]
Pathol Biol (Paris). 1986 Jun;34(6):715-21.
5
An HLA-All association with the hemochromatosis allele?HLA与血色素沉着病等位基因存在关联?
Clin Genet. 1983 Sep;24(3):171-6. doi: 10.1111/j.1399-0004.1983.tb02234.x.
6
Mapping the locus for hereditary hemochromatosis: localization between HLA-B and HLA-A.遗传性血色素沉着症基因座的定位:定位于HLA - B和HLA - A之间。
Am J Hum Genet. 1986 Jun;38(6):805-11.
7
Idiopathic hemochromatosis: linkage with HLA.
Tissue Antigens. 1978 May;11(5):471-4. doi: 10.1111/j.1399-0039.1978.tb01286.x.
8
Is all genetic (hereditary) hemochromatosis HLA-associated.所有遗传性血色素沉着症都与人类白细胞抗原(HLA)相关吗?
Ann N Y Acad Sci. 1988;526:23-33. doi: 10.1111/j.1749-6632.1988.tb55489.x.
9
HLA as a marker of the hemochromatosis gene in Sweden.HLA作为瑞典血色素沉着症基因的一个标记。
Hum Genet. 1984;68(1):62-6. doi: 10.1007/BF00293874.
10
[Idiopathic hemochromatosis: association with antigens of the HLA system].
Med Klin (Munich). 1991 Oct 15;86(10):503-7.